Vulva Cancer
18
9
10
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
Danish Vulva Cancer Recurrence Study
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
3D Printed Custom Applicators for HDR BT (DISCO)
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
SLN Mapping and ICG Dye for Vulvar Cancer
Simulation Supported Vulva Cancer and Self-Examination on Knowledge, Skills and Attitude
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
Sentinel Node Extended in Squamous Cell Vulvar Cancer
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery